Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Acidosis, Lactic
Tramadol poisoning with hyperamylasemia.
Biliary Tract Diseases
The pancreatic enzymes value in the diagnosis of acute pancreatitis and acute biliary tract diseases.
Breast Neoplasms
A unique case of breast carcinoma producing pancreatic-type isoamylase.
Breast Neoplasms
Pancreatic-type isoamylase in breast carcinoma.
Carcinoma
A prospective study of amylase-rich pleural effusions with special reference to amylase isoenzyme analysis.
Carcinoma
Nonpancreatic-type hyperamylasemia associated with pancreatic cancer.
Carcinoma
Unusual anodic migrating isoamylase differentiates selected malignant from nonmalignant ascites.
Carcinoma
[Serum pancreatic enzymes in the diagnosis of carcinoma of the pancreas]
Carcinoma, Non-Small-Cell Lung
Glycogen debranching enzyme (AGL) is a novel regulator of non-small cell lung cancer growth.
Cardiomyopathies
Spectrum of AGL mutations in Chinese patients with glycogen storage disease type III: identification of 31 novel mutations.
Celiac Disease
Serum isoamylase activities in cystic fibrosis patients, determined by an inhibitory assay.
Cholangitis, Sclerosing
The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis.
Cholelithiasis
Differential determination of serum isoamylase using an amylase inhibitor and its clinical application.
Colonic Diseases
Elevated pancreatic enzymes in inflammatory bowel disease are associated with extensive disease.
Craniocerebral Trauma
Serum amylase and its isoenzymes: a clarification of their implications in trauma.
Crohn Disease
Hyperamylasemia in inflammatory bowel disease.
Cystic Fibrosis
Comparison of the diagnostic value of serum pancreatic isoamylase and immunoreactive trypsin measurement in patients with cystic fibrosis.
Cystic Fibrosis
Cystic fibrosis serum pancreatic amylase. Useful discriminator of exocrine function.
Cystic Fibrosis
Cystic fibrosis--its biochemical detection.
Cystic Fibrosis
Isoamylase abnormalities in cystic fibrosis.
Cystic Fibrosis
Letters to the editor: Isoamylase abnormalities in cystic fibrosis.
Cystic Fibrosis
Serum immuno reactive trypsin and pancreatic isoamylase in older patients with cystic fibrosis.
Cystic Fibrosis
Serum isoamylase activities in cystic fibrosis patients, determined by an inhibitory assay.
Cystic Fibrosis
Serum pancreatic isoamylases in the diagnosis of cystic fibrosis heterozygotes: A non-valuable test.
Cystic Fibrosis
Serum pancreatic lipase activity in cystic fibrosis.
Cysts
Isoamylases and their thermolability in serum and cyst fluid from patients with pancreatic pseudocysts.
Diabetes Mellitus
Differential determination of serum isoamylase using an amylase inhibitor and its clinical application.
Diabetes Mellitus
Exocrine pancreatic function in diabetes mellitus.
Diabetes Mellitus
Renal isoamylase clearance as a measure of altered renal charge selectivity in patients with diabetes mellitus.
Diabetes Mellitus
Serum concentration of cathodic trypsin-like immunoreactivity and pancreatic isoamylase in insulin-dependent diabetes mellitus.
Diabetes Mellitus
Serum isoamylase activities in diabetes mellitus.
Diabetes Mellitus, Type 1
Exocrine pancreatic function in insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 1
Glomerular charge selectivity in type 1 (insulin-dependent) diabetes mellitus.
Diabetes Mellitus, Type 1
Serum concentration of cathodic trypsin-like immunoreactivity and pancreatic isoamylase in insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 1
Serum lipase, isoamylase and pancreatic function test (PFT) in juvenile-onset insulin-dependent diabetes mellitus.
Duodenitis
[Pseudo acute pancreatitis: a syndrome mimicked by a multiple parasitic duodenitis. Analysis of 7 case]
Eosinophilia
[Pseudo acute pancreatitis: a syndrome mimicked by a multiple parasitic duodenitis. Analysis of 7 case]
Exocrine Pancreatic Insufficiency
Behaviour of serum pancreatic enzymes in chronic pancreatitis.
Exocrine Pancreatic Insufficiency
Comparative study of serum pancreatic isoamylase, lipase, and trypsin-like immunoreactivity in pancreatic disease.
Exocrine Pancreatic Insufficiency
Diagnostic and therapeutic applications of bentiromide screening test for exocrine pancreatic insufficiency in patients with cystic fibrosis. Comparison with other tests of exocrine pancreatic disease.
Exocrine Pancreatic Insufficiency
Estimation of serum pancreatic isoamylase: its role in the diagnosis of exocrine pancreatic insufficiency.
Exocrine Pancreatic Insufficiency
Fecal isoamylase activity in patients with pancreatic diseases.
Exocrine Pancreatic Insufficiency
Relation between serum pancreatic isoamylase concentration and pancreatic exocrine function.
Exocrine Pancreatic Insufficiency
Salivary isoamylase in duodenal aspirates.
Exocrine Pancreatic Insufficiency
Sensitivity and specificity of canine serum total amylase and isoamylase activity determinations.
Exocrine Pancreatic Insufficiency
Serum isoamylase as a test for pancreatic insufficiency.
Exocrine Pancreatic Insufficiency
Serum isoamylase values in normal dogs and dogs with exocrine pancreatic insufficiency.
Exocrine Pancreatic Insufficiency
Serum isoamylases in chronic pancreatitis.
Exocrine Pancreatic Insufficiency
Serum pancreatic isoamylase activity in pancreatic disease.
Exocrine Pancreatic Insufficiency
Value of pancreatic-type isoamylase assay as an index of pancreatic insufficiency.
Glomerulonephritis, Membranous
Glomerular charge selectivity in primary glomerulopathies.
Glycogen Storage Disease
A c.3216_3217delGA mutation in AGL gene in Tunisian patients with a glycogen storage disease type III: evidence of a founder effect.
Glycogen Storage Disease
A founder AGL mutation causing glycogen storage disease type IIIa in Inuit identified through whole-exome sequencing: a case series.
Glycogen Storage Disease
A mutation analysis of the AGL gene in Korean patients with glycogen storage disease type III.
Glycogen Storage Disease
A nonsense mutation due to a single base insertion in the 3'-coding region of glycogen debranching enzyme gene associated with a severe phenotype in a patient with glycogen storage disease type IIIa.
Glycogen Storage Disease
A novel donor splice site mutation in the glycogen debranching enzyme gene is associated with glycogen storage disease type III.
Glycogen Storage Disease
A Novel Gene Therapy Approach for GSD III Using an AAV Vector Encoding a Bacterial Glycogen Debranching Enzyme.
Glycogen Storage Disease
A Novel Nonsense Mutation of the AGL Gene in a Romanian Patient with Glycogen Storage Disease Type IIIa.
Glycogen Storage Disease
A novel point mutation in an acceptor splice site of intron 32 (IVS32 A-12-->G) but no exon 3 mutations in the glycogen debranching enzyme gene in a homozygous patient with glycogen storage disease type IIIb.
Glycogen Storage Disease
A single-base deletion in the 3'-coding region of glycogen-debranching enzyme is prevalent in glycogen storage disease type IIIA in a population of North African Jewish patients.
Glycogen Storage Disease
Beneficial Effects of Modified Atkins Diet in Glycogen Storage Disease Type IIIa.
Glycogen Storage Disease
Biochemical and molecular investigation of two Korean patients with glycogen storage disease type III.
Glycogen Storage Disease
Characterization of a canine model of glycogen storage disease type IIIa.
Glycogen Storage Disease
Cognitive profile of patients with glycogen storage disease type III: a clinical description of seven cases.
Glycogen Storage Disease
Compound heterozygous patient with glycogen storage disease type III: identification of two novel AGL mutations, a donor splice site mutation of Chinese origin and a 1-bp deletion of Japanese origin.
Glycogen Storage Disease
Distinct Clinical and Genetic Findings in Iranian Patients With Glycogen Storage Disease Type 3.
Glycogen Storage Disease
Distinct mutations in the glycogen debranching enzyme found in glycogen storage disease type III lead to impairment in diverse cellular functions.
Glycogen Storage Disease
DNA-based subtyping of glycogen storage disease type III: mutation and haplotype analysis of the AGL gene in Chinese.
Glycogen Storage Disease
Echocardiographic manifestations of Glycogen Storage Disease III: increase in wall thickness and left ventricular mass over time.
Glycogen Storage Disease
Expression of a Functional Recombinant Human Glycogen Debranching Enzyme (hGDE) in N. benthamiana Plants and in Hairy Root Cultures.
Glycogen Storage Disease
Expression of catalytically active human multifunctional glycogen-debranching enzyme and lysosomal acid alpha-glucosidase in insect cells.
Glycogen Storage Disease
Genotype-phenotype correlation in two frequent mutations and mutation update in type III glycogen storage disease.
Glycogen Storage Disease
Glycogen Debrancher Enzyme Deficiency Myopathy.
Glycogen Storage Disease
Glycogen debranching enzyme: purification, antibody characterization, and immunoblot analyses of type III glycogen storage disease.
Glycogen Storage Disease
Glycogen storage disease type III: A novel Agl knockout mouse model.
Glycogen Storage Disease
Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome.
Glycogen Storage Disease
Glycogen storage disease type IIIa in curly-coated retrievers.
Glycogen Storage Disease
Glycogen storage disease type IIIa presenting as non-ketotic hypoglycemia: use of a newly approved commercially available mutation analysis to non-invasively confirm the diagnosis.
Glycogen Storage Disease
Glycogen storage disease type IIIa: first report of a causative missense mutation (G1448R) of the glycogen debranching enzyme gene found in a homozygous patient.
Glycogen Storage Disease
Hepatic and neuromuscular forms of glycogenosis type III: nine mutations in AGL.
Glycogen Storage Disease
Heterogeneous mutations in the glycogen-debranching enzyme gene are responsible for glycogen storage disease type IIIa in Japan.
Glycogen Storage Disease
High frequency of W1327X mutation in glycogen storage disease type III patients from central Tunisia.
Glycogen Storage Disease
Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III.
Glycogen Storage Disease
Intron retention is among six unreported AGL mutations identified in Malaysian GSD III patients.
Glycogen Storage Disease
Involvement of glycogen debranching enzyme in bladder cancer.
Glycogen Storage Disease
Isolation and nucleotide sequence of human liver glycogen debranching enzyme mRNA: identification of multiple tissue-specific isoforms.
Glycogen Storage Disease
Leucocyte alpha-1,4- and alpha-1,6-glucosidase activities towards oligosaccharides in late onset glycogenosis type II.
Glycogen Storage Disease
Long term longitudinal study of muscle function in patients with glycogen storage disease type IIIa.
Glycogen Storage Disease
Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey.
Glycogen Storage Disease
Molecular analysis of the AGL gene: identification of 25 novel mutations and evidence of genetic heterogeneity in patients with Glycogen Storage Disease Type III.
Glycogen Storage Disease
Molecular and biochemical characterization of a novel intronic single point mutation in a Tunisian family with glycogen storage disease type III.
Glycogen Storage Disease
Molecular and biochemical characterization of Tunisian patients with glycogen storage disease type III.
Glycogen Storage Disease
Molecular characterization of Egyptian patients with glycogen storage disease type IIIa.
Glycogen Storage Disease
Molecular characterization of glycogen storage disease type III.
Glycogen Storage Disease
Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p.R1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations.
Glycogen Storage Disease
Mouse model of glycogen storage disease type III.
Glycogen Storage Disease
Multidisciplinary management of an obstetric patient with glycogen storage disease type 3.
Glycogen Storage Disease
Mutation Analysis in Glycogen Storage Disease Type III Patients in the Netherlands: Novel Genotype-Phenotype Relationships and Five Novel Mutations in the AGL Gene.
Glycogen Storage Disease
Mutational analysis of the AGL gene: five novel mutations in GSD III patients.
Glycogen Storage Disease
Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III.
Glycogen Storage Disease
Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle.
Glycogen Storage Disease
Natural Progression of Canine Glycogen Storage Disease Type IIIa.
Glycogen Storage Disease
Polymorphic markers of the glycogen debranching enzyme gene allowing linkage analysis in families with glycogen storage disease type III.
Glycogen Storage Disease
Prenatal diagnosis and carrier detection for glycogen storage disease type III using polymorphic DNA markers.
Glycogen Storage Disease
Reduced bone mineral density in glycogen storage disease type III: evidence for a possible connection between metabolic imbalance and bone homeostasis.
Glycogen Storage Disease
Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression.
Glycogen Storage Disease
Role in Tumor Growth of a Glycogen Debranching Enzyme Lost in Glycogen Storage Disease.
Glycogen Storage Disease
Simultaneous absence of alpha-1,4-glucosidase and alpha-1,6-glucosidase activities (pH 4) in tissues of children with type II glycogen storage disease.
Glycogen Storage Disease
Spectrum of AGL mutations in Chinese patients with glycogen storage disease type III: identification of 31 novel mutations.
Glycogen Storage Disease
Spectrum of amyloglucosidase mutations in Asian Indian patients with Glycogen storage disease type III.
Glycogen Storage Disease
Two new mutations in the 3' coding region of the glycogen debranching enzyme in a glycogen storage disease type IIIa Ashkenazi Jewish patient.
Glycogen Storage Disease
[Diagnosis of glycogen storage disease type IIIA by detecting glycogen debranching enzyme activity, glycogen content and structure in muscle]
Glycogen Storage Disease
[Molecular and clinical characterization of Colombian patients suffering from type III glycogen storage disease].
Glycogen Storage Disease Type II
Leucocyte alpha-1,4- and alpha-1,6-glucosidase activities towards oligosaccharides in late onset glycogenosis type II.
Glycogen Storage Disease Type III
A c.3216_3217delGA mutation in AGL gene in Tunisian patients with a glycogen storage disease type III: evidence of a founder effect.
Glycogen Storage Disease Type III
A founder AGL mutation causing glycogen storage disease type IIIa in Inuit identified through whole-exome sequencing: a case series.
Glycogen Storage Disease Type III
A mutation analysis of the AGL gene in Korean patients with glycogen storage disease type III.
Glycogen Storage Disease Type III
A nonsense mutation due to a single base insertion in the 3'-coding region of glycogen debranching enzyme gene associated with a severe phenotype in a patient with glycogen storage disease type IIIa.
Glycogen Storage Disease Type III
A novel donor splice site mutation in the glycogen debranching enzyme gene is associated with glycogen storage disease type III.
Glycogen Storage Disease Type III
A Novel Gene Therapy Approach for GSD III Using an AAV Vector Encoding a Bacterial Glycogen Debranching Enzyme.
Glycogen Storage Disease Type III
A Novel Nonsense Mutation of the AGL Gene in a Romanian Patient with Glycogen Storage Disease Type IIIa.
Glycogen Storage Disease Type III
A novel point mutation in an acceptor splice site of intron 32 (IVS32 A-12-->G) but no exon 3 mutations in the glycogen debranching enzyme gene in a homozygous patient with glycogen storage disease type IIIb.
Glycogen Storage Disease Type III
A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease.
Glycogen Storage Disease Type III
A single-base deletion in the 3'-coding region of glycogen-debranching enzyme is prevalent in glycogen storage disease type IIIA in a population of North African Jewish patients.
Glycogen Storage Disease Type III
Beneficial Effects of Modified Atkins Diet in Glycogen Storage Disease Type IIIa.
Glycogen Storage Disease Type III
Biochemical and molecular investigation of two Korean patients with glycogen storage disease type III.
Glycogen Storage Disease Type III
Clinical, biochemical and genetic features of glycogen debranching enzyme deficiency.
Glycogen Storage Disease Type III
Cognitive profile of patients with glycogen storage disease type III: a clinical description of seven cases.
Glycogen Storage Disease Type III
Compound heterozygous patient with glycogen storage disease type III: identification of two novel AGL mutations, a donor splice site mutation of Chinese origin and a 1-bp deletion of Japanese origin.
Glycogen Storage Disease Type III
Distinct Clinical and Genetic Findings in Iranian Patients With Glycogen Storage Disease Type 3.
Glycogen Storage Disease Type III
Distinct mutations in the glycogen debranching enzyme found in glycogen storage disease type III lead to impairment in diverse cellular functions.
Glycogen Storage Disease Type III
DNA-based subtyping of glycogen storage disease type III: mutation and haplotype analysis of the AGL gene in Chinese.
Glycogen Storage Disease Type III
Echocardiographic manifestations of Glycogen Storage Disease III: increase in wall thickness and left ventricular mass over time.
Glycogen Storage Disease Type III
Expression of a Functional Recombinant Human Glycogen Debranching Enzyme (hGDE) in N. benthamiana Plants and in Hairy Root Cultures.
Glycogen Storage Disease Type III
Expression of catalytically active human multifunctional glycogen-debranching enzyme and lysosomal acid alpha-glucosidase in insect cells.
Glycogen Storage Disease Type III
Genotype-phenotype correlation in two frequent mutations and mutation update in type III glycogen storage disease.
Glycogen Storage Disease Type III
Glucose-free/high-protein diet improves hepatomegaly and exercise intolerance in glycogen storage disease type III mice.
Glycogen Storage Disease Type III
Glycogen Debrancher Enzyme Deficiency Myopathy.
Glycogen Storage Disease Type III
Glycogen debranching enzyme deficiency: long-term study of serum enzyme activities and clinical features.
Glycogen Storage Disease Type III
Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?
Glycogen Storage Disease Type III
Glycogen storage disease type III: A novel Agl knockout mouse model.
Glycogen Storage Disease Type III
Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome.
Glycogen Storage Disease Type III
Glycogen storage disease type IIIa presenting as non-ketotic hypoglycemia: use of a newly approved commercially available mutation analysis to non-invasively confirm the diagnosis.
Glycogen Storage Disease Type III
Glycogen storage disease type IIIa: first report of a causative missense mutation (G1448R) of the glycogen debranching enzyme gene found in a homozygous patient.
Glycogen Storage Disease Type III
High frequency of W1327X mutation in glycogen storage disease type III patients from central Tunisia.
Glycogen Storage Disease Type III
Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III.
Glycogen Storage Disease Type III
Intron retention is among six unreported AGL mutations identified in Malaysian GSD III patients.
Glycogen Storage Disease Type III
Involvement of glycogen debranching enzyme in bladder cancer.
Glycogen Storage Disease Type III
Isolation and nucleotide sequence of human liver glycogen debranching enzyme mRNA: identification of multiple tissue-specific isoforms.
Glycogen Storage Disease Type III
Long term longitudinal study of muscle function in patients with glycogen storage disease type IIIa.
Glycogen Storage Disease Type III
Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey.
Glycogen Storage Disease Type III
Molecular analysis of the AGL gene: identification of 25 novel mutations and evidence of genetic heterogeneity in patients with Glycogen Storage Disease Type III.
Glycogen Storage Disease Type III
Molecular and biochemical characterization of a novel intronic single point mutation in a Tunisian family with glycogen storage disease type III.
Glycogen Storage Disease Type III
Molecular and biochemical characterization of Tunisian patients with glycogen storage disease type III.
Glycogen Storage Disease Type III
Molecular characterization of glycogen storage disease type III.
Glycogen Storage Disease Type III
Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p.R1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations.
Glycogen Storage Disease Type III
Multidisciplinary management of an obstetric patient with glycogen storage disease type 3.
Glycogen Storage Disease Type III
Mutation Analysis in Glycogen Storage Disease Type III Patients in the Netherlands: Novel Genotype-Phenotype Relationships and Five Novel Mutations in the AGL Gene.
Glycogen Storage Disease Type III
Mutational analysis of the AGL gene: five novel mutations in GSD III patients.
Glycogen Storage Disease Type III
Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III.
Glycogen Storage Disease Type III
Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle.
Glycogen Storage Disease Type III
Polymorphic markers of the glycogen debranching enzyme gene allowing linkage analysis in families with glycogen storage disease type III.
Glycogen Storage Disease Type III
Prenatal diagnosis and carrier detection for glycogen storage disease type III using polymorphic DNA markers.
Glycogen Storage Disease Type III
Reduced bone mineral density in glycogen storage disease type III: evidence for a possible connection between metabolic imbalance and bone homeostasis.
Glycogen Storage Disease Type III
Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression.
Glycogen Storage Disease Type III
Spectrum of AGL mutations in Chinese patients with glycogen storage disease type III: identification of 31 novel mutations.
Glycogen Storage Disease Type III
Spectrum of amyloglucosidase mutations in Asian Indian patients with Glycogen storage disease type III.
Glycogen Storage Disease Type III
Two new mutations in the 3' coding region of the glycogen debranching enzyme in a glycogen storage disease type IIIa Ashkenazi Jewish patient.
Glycogen Storage Disease Type III
[Diagnosis of glycogen storage disease type IIIA by detecting glycogen debranching enzyme activity, glycogen content and structure in muscle]
Glycogen Storage Disease Type III
[Glycogen debranching enzyme deficiency (Forbes-Cori disease)]
Glycogen Storage Disease Type III
[Glycogen debranching enzyme deficiency]
Graft vs Host Disease
Isoamylase levels in bone marrow transplant patients are affected by total body irradiation and not by graft-versus-host disease.
Hepatitis
Mild pancreatic damage in acute viral hepatitis.
Hepatitis
Serum isoamylases in acute and chronic liver disease.
Hepatitis, Chronic
Serum isoamylases in acute and chronic liver disease.
Hepatomegaly
A Japanese patient with cardiomyopathy caused by a novel mutation R285X in the AGL gene.
Hepatomegaly
Glucose-free/high-protein diet improves hepatomegaly and exercise intolerance in glycogen storage disease type III mice.
Hepatomegaly
Spectrum of AGL mutations in Chinese patients with glycogen storage disease type III: identification of 31 novel mutations.
Hepatomegaly
[Diagnosis of glycogen storage disease type IIIA by detecting glycogen debranching enzyme activity, glycogen content and structure in muscle]
Hyperlipidemias
[Diagnosis of glycogen storage disease type IIIA by detecting glycogen debranching enzyme activity, glycogen content and structure in muscle]
Hypoglycemia
A Japanese patient with cardiomyopathy caused by a novel mutation R285X in the AGL gene.
Hypoglycemia
Glucose-free/high-protein diet improves hepatomegaly and exercise intolerance in glycogen storage disease type III mice.
Hypoglycemia
Spectrum of AGL mutations in Chinese patients with glycogen storage disease type III: identification of 31 novel mutations.
Hypoglycemia
[Diagnosis of glycogen storage disease type IIIA by detecting glycogen debranching enzyme activity, glycogen content and structure in muscle]
Infections
Amylases of the genital tract. II. Peritoneal fluid isoamylases in acute salpingitis.
Irritable Bowel Syndrome
Differential determination of serum isoamylase using an amylase inhibitor and its clinical application.
isoamylase deficiency
Clinical, biochemical and genetic features of glycogen debranching enzyme deficiency.
isoamylase deficiency
Distinct Clinical and Genetic Findings in Iranian Patients With Glycogen Storage Disease Type 3.
isoamylase deficiency
Echocardiographic manifestations of Glycogen Storage Disease III: increase in wall thickness and left ventricular mass over time.
isoamylase deficiency
Glucose-free/high-protein diet improves hepatomegaly and exercise intolerance in glycogen storage disease type III mice.
isoamylase deficiency
Glycogen debranching enzyme deficiency: long-term study of serum enzyme activities and clinical features.
isoamylase deficiency
Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome.
isoamylase deficiency
Severe acute pancreatitis and normal serum amylase activity due to pancreatic isoamylase deficiency.
isoamylase deficiency
[Glycogen debranching enzyme deficiency (Forbes-Cori disease)]
isoamylase deficiency
[Glycogen debranching enzyme deficiency]
Kidney Failure, Chronic
Differential determination of serum isoamylase using an amylase inhibitor and its clinical application.
Kidney Failure, Chronic
Immunoreactive trypsin and pancreatic isoamylase activity in serum of patients with chronic renal failure or hepatic cirrhosis.
Kidney Failure, Chronic
Pancreatic enzymes in patients with end-stage renal disease maintained on hemodialysis.
Kidney Failure, Chronic
Pancreatic-type hyperamylasemia in end-stage renal disease.
Kidney Failure, Chronic
Serum amylase and isoamylase in chronic renal failure.
Kidney Failure, Chronic
Serum isoamylase measurements in pancreatitis complicating chronic renal failure.
Kidney Failure, Chronic
The value of alpha-amylase and isoamylase determination in chronic renal failure patients.
Liver Cirrhosis
Differential determination of serum isoamylase using an amylase inhibitor and its clinical application.
Liver Cirrhosis
Immunoreactive trypsin and pancreatic isoamylase activity in serum of patients with chronic renal failure or hepatic cirrhosis.
Liver Cirrhosis
Serum isoamylases in acute and chronic liver disease.
Liver Cirrhosis, Biliary
The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis.
Liver Diseases
A cause of hyperamylasemia associated with chronic liver disease.
Liver Diseases
Hyperamylasemia with an abnormal isoamylase distribution in patients with liver diseases.
Liver Diseases
Serum isoamylases in acute and chronic liver disease.
Liver Diseases
Serum isoamylases in liver diseases.
Lung Neoplasms
Amylase in the lung.
Lung Neoplasms
Glycogen debranching enzyme (AGL) is a novel regulator of non-small cell lung cancer growth.
Lung Neoplasms
Salivary-type hyperamylasemia in primary lung cancer: observation of a possible precursor of the salivary-type isoamylase.
Lung Neoplasms
Unusual isomaylase in cancer-associated hyperamylasemia.
Lupus Erythematosus, Systemic
Systemic lupus erythematosus presenting initially with acute pancreatitis and a review of the literature.
Multiple Myeloma
[Tumor producing amylase]
Mumps
Differential determination of serum isoamylase using an amylase inhibitor and its clinical application.
Muscle Weakness
Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression.
Muscular Diseases
Efficacy of cornstarch therapy in type III glycogen-storage disease.
Muscular Diseases
Spectrum of AGL mutations in Chinese patients with glycogen storage disease type III: identification of 31 novel mutations.
Myocardial Infarction
Combination of miglitol, an anti-diabetic drug, and nicorandil markedly reduces myocardial infarct size through opening the mitochondrial K(ATP) channels in rabbits.
Myocardial Infarction
Combination of N-methyl-1-deoxynojirimycin and ischemic preconditioning markedly reduces the size of myocardial infarcts in rabbits.
Neoplasms
alpha-Amylase in resectable lung cancer.
Neoplasms
Amylase producing lung cancer. Electronmicroscopical and biochemical studies.
Neoplasms
Elevated activity of pancreatic type amylase in the urine as an early indicator of pancreatic tumors in hamsters.
Neoplasms
Hyperamylasemia with papillary serous cystadenocarcinoma of the ovary.
Neoplasms
Metabolic phenotype of bladder cancer.
Neoplasms
Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report.
Neoplasms
Role in Tumor Growth of a Glycogen Debranching Enzyme Lost in Glycogen Storage Disease.
Neoplasms
Salivary-type hyperamylasemia in primary lung cancer: observation of a possible precursor of the salivary-type isoamylase.
Neoplasms
Studies of the effects of radiation or surgery on the salivary amylase activity and the isoamylase composition in salivary gland tumours.
Neoplasms
Targeting glycogen metabolism in bladder cancer.
Neoplasms
Tumor-associated hyperamylasemia.
Neoplasms
Unusual anodic migrating isoamylase differentiates selected malignant from nonmalignant ascites.
Neoplasms
[Clinical aspects and therapy of parotid tumors]
Obesity
Preferential salivary-type hypoamylasemia in obese children.
Ovarian Neoplasms
[Changes in activity of alpha amylase and its salivary isoenzyme in serum and urine after surgical treatment of ovarian neoplasms]
Ovarian Neoplasms
[Tumor producing amylase]
Pancreatic Cyst
Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease.
Pancreatic Diseases
Assessment of a rapid pancreatic isoamylase assay as a screening test for chronic pancreatic disease.
Pancreatic Diseases
Clinical application of organ specific isoamylases.
Pancreatic Diseases
Clinical significance of serum pancreatic enzymes in the quiescent phase of chronic pancreatitis.
Pancreatic Diseases
Comparative study of serum pancreatic isoamylase, lipase, and trypsin-like immunoreactivity in pancreatic disease.
Pancreatic Diseases
Concentration of immunoreactive trypsin and activity of pancreatic isoamylase in serum compared in pancreatic diseases.
Pancreatic Diseases
Diagnostic utility of a new monoclonal antibody pancreatic isoamylase assay in chronic pancreatic diseases.
Pancreatic Diseases
Diagnostic value of serum elastase 1 in pancreatic disease.
Pancreatic Diseases
Fecal isoamylase activity in patients with pancreatic diseases.
Pancreatic Diseases
Isoamylase determination by isoelectric focusing in pancreatic disorders. A potential clinical aid.
Pancreatic Diseases
Isoamylases in pancreatic carcinoma and chronic relapsing pancreatitis.
Pancreatic Diseases
Macroamylasemia and other chronic nonspecific hyperamylasemias: chemical oddities or clinical entities?
Pancreatic Diseases
Relation of electrophoretic pattern of amylase isoenzymes to severity of pancreatic disease.
Pancreatic Diseases
Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease.
Pancreatic Diseases
Sensitivity and specificity of canine serum total amylase and isoamylase activity determinations.
Pancreatic Diseases
Serum amylase and isoamylase values in dogs with pancreatic disease.
Pancreatic Diseases
Serum isoamylase activities in pancreatic diseases.
Pancreatic Diseases
Serum isoamylase pattern in obstructive pancreatic disease.
Pancreatic Diseases
Serum levels of six pancreatic enzymes as related to the degree of renal dysfunction.
Pancreatic Diseases
Serum pancreatic isoamylase activity in pancreatic disease.
Pancreatic Diseases
[Immunotrypsinogen and amylase isoenzymes in pancreatic diseases]
Pancreatic Diseases
[Serum pancreatic secretory trypsin inhibitor (PSTI), amylase activity and pancreatic isoamylase activity in pancreatic diseases]
Pancreatic Neoplasms
Comparative study of serum pancreatic isoamylase, lipase, and trypsin-like immunoreactivity in pancreatic disease.
Pancreatic Neoplasms
Diagnostic utility of a new monoclonal antibody pancreatic isoamylase assay in chronic pancreatic diseases.
Pancreatic Neoplasms
Differential determination of serum isoamylase using an amylase inhibitor and its clinical application.
Pancreatic Neoplasms
Fecal isoamylase activity in patients with pancreatic diseases.
Pancreatic Neoplasms
Serum phospholipase A2 activity in chronic pancreatic diseases.
Pancreatic Neoplasms
Structure of a polysaccharide from Gastrodia elata Bl., and oligosaccharides prepared thereof with anti-pancreatic cancer cell growth activities
Pancreatic Neoplasms
Urinary phospholipase A2 excretion in chronic pancreatic diseases.
Pancreatic Neoplasms
[Serum pancreatic enzymes in the diagnosis of carcinoma of the pancreas]
Pancreatic Pseudocyst
Isoamylase pattern diagnostic of pancreatic pseudocyst.
Pancreatic Pseudocyst
Isoamylases and their thermolability in serum and cyst fluid from patients with pancreatic pseudocysts.
Pancreatic Pseudocyst
Pancreatic pseudocyst associated with eating disorder.
Pancreatic Pseudocyst
Puzzling persistent hyperamylasemia, probably neither pancreatic nor pathologic.
Pancreatic Pseudocyst
Serum pancreatic isoamylase activity in pancreatic disease.
Pancreatitis
A correlation between clinical pancreatitis and isoenzyme patterns of amylase.
Pancreatitis
Acute alcohol intoxication: significance of the amylase level.
Pancreatitis
Alcohol Abuse and Pancreatic Diseases: An Overview.
Pancreatitis
Alcoholic pancreatitis and parotitis: utility of lipase and urinary amylase clearance determinations.
Pancreatitis
Amylase isoenzymes in the acute abdomen: an adjunct in those patients with elevated total amylase.
Pancreatitis
Amylase, lipase, pancreatic isoamylase, and phospholipase A in diagnosis of acute pancreatitis.
Pancreatitis
Amylase-creatinine clearance ratios and serum amylase isoenzymes in moderate renal insufficiency.
Pancreatitis
Clinical validity of a continuous colorimetric method for serum lipase.
Pancreatitis
Clinical value of routine isoamylase analysis of hyperamylasemia.
Pancreatitis
Comparative study of serum pancreatic isoamylase, lipase, and trypsin-like immunoreactivity in pancreatic disease.
Pancreatitis
Comparison of serum amylase pancreatic isoamylase and lipase in patients with hyperamylasemia.
Pancreatitis
Correlation of pancreatic enzyme levels with the patient's recovery from acute edematous pancreatitis.
Pancreatitis
Diagnostic assays in acute pancreatitis. A study of sensitivity and specificity.
Pancreatitis
Diagnostic value of routine isoamylase assay of hyperamylasemic serum.
Pancreatitis
Diagnostic value of serum elastase 1 in pancreatic disease.
Pancreatitis
Differential determination of serum isoamylase using an amylase inhibitor and its clinical application.
Pancreatitis
Diseased dogs isoamylases in clinically normal and diseased dogs.
Pancreatitis
Does subclinical pancreatic inflammation occur after parathyroidectomy?
Pancreatitis
Effects of ischemia on the human pancreas.
Pancreatitis
Evaluation and comparison of cathodic trypsin-like immunoreactivity, pancreatic lipase and pancreatic isoamylase in the diagnosis of acute pancreatitis in 849 consecutive patients with acute abdominal pain.
Pancreatitis
Exocrine pancreatic function (serum immunoreactive trypsin, fecal chymotrypsin, and pancreatic isoamylase) in Indian diabetics.
Pancreatitis
Fecal isoamylase activity in patients with pancreatic diseases.
Pancreatitis
Hyperamylasemia after cardiac surgery. Incidence, significance, and management.
Pancreatitis
Isoamylase levels in bone marrow transplant patients are affected by total body irradiation and not by graft-versus-host disease.
Pancreatitis
Mechanism of increased renal clearnace of amylase/creatinine in acute pancreatitis.
Pancreatitis
Multicenter evaluation of a specific pancreatic isoamylase assay based on a double monoclonal-antibody technique.
Pancreatitis
Nonpancreatic-type hyperamylasemia associated with pancreatic cancer.
Pancreatitis
Pancreatic enzymes in chronic renal failure.
Pancreatitis
Pancreatic enzymes in patients with end-stage renal disease maintained on hemodialysis.
Pancreatitis
Pancreatitis-like isoamylase pattern in normal persons.
Pancreatitis
Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report.
Pancreatitis
Radioimmunoassay for human pancreatic lipase in acute pancreatitis.
Pancreatitis
Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease.
Pancreatitis
Sensitivity and specificity of canine serum total amylase and isoamylase activity determinations.
Pancreatitis
Serum amylase and isoamylases and their origins in healthy dogs and dogs with experimentally induced acute pancreatitis.
Pancreatitis
Serum amylase, isoamylase, and lipase in the acute abdomen. Their diagnostic value for acute pancreatitis.
Pancreatitis
Serum isoamylase measurements in pancreatitis complicating chronic renal failure.
Pancreatitis
Serum pancreatic enzyme assays in acute abdomen: a comparative prospective study.
Pancreatitis
Serum pancreatic enzyme behavior during the course of acute pancreatitis.
Pancreatitis
Serum pancreatic isoamylase activity in pancreatic disease.
Pancreatitis
Serum tests for pancreatitis in patients with abdominal pain.
Pancreatitis
Severe acute pancreatitis and normal serum amylase activity due to pancreatic isoamylase deficiency.
Pancreatitis
Studies on serum amylase in normal man and in acute pancreatitis.
Pancreatitis
Systemic lupus erythematosus presenting initially with acute pancreatitis and a review of the literature.
Pancreatitis
The pancreatic enzymes value in the diagnosis of acute pancreatitis and acute biliary tract diseases.
Pancreatitis
The role of serum isoamylase and lipase determinations in clinical practice.
Pancreatitis
Time course of changes in serum activity of the P3 isoform of pancreatic amylase isoenzyme in patients with acute pancreatitis.
Pancreatitis
Use of amylase isoenzymes in laboratory evaluation of hyperamylasemia.
Pancreatitis
Value of the P3 amylase fraction as an indicator of the long-term prognosis of acute pancreatitis.
Pancreatitis
What is the best biochemical test to diagnose acute pancreatitis? A prospective clinical study.
Pancreatitis
Where does serum amylase come from and where does it go?
Pancreatitis
[A study of lipase, amylase and isoamylase in acute pancreatitis]
Pancreatitis
[Diagnostic value of a diagnostic strip for determining urinary amylase]
Pancreatitis
[Diagnostic value of lipase and isoamylase determination. Monitoring studies in patients with proven and suspected pancreatitis]
Pancreatitis
[Diagnostic value of various laboratory parameters in acute pancreatitis]
Pancreatitis
[Importance of the delay in the serum determination of amylase, lipase and isoamylase P3 in the diagnosis of acute pancreatitis]
Pancreatitis
[Significance of immunoreactive lipase in the diagnosis of pancreatic diseases]
Pancreatitis
[Significance of serum levels of elastase 1 and pancreatic isoamylase in acute and chronic recurrent pancreatitis]
Pancreatitis, Alcoholic
Alcoholic pancreatitis and parotitis: utility of lipase and urinary amylase clearance determinations.
Pancreatitis, Alcoholic
Clinical value of serum pancreatic enzymes in acute alcohol intoxication and acute alcoholic pancreatitis.
Pancreatitis, Chronic
A preliminary report on urinary BT-PABA/PAS excretion index, serum pancreatic isoamylase and faecal chymotrypsin tests of pancreatic dysfunction in Sowetan Africans.
Pancreatitis, Chronic
Assessment of a rapid pancreatic isoamylase assay as a screening test for chronic pancreatic disease.
Pancreatitis, Chronic
Behaviour of serum pancreatic enzymes in chronic pancreatitis.
Pancreatitis, Chronic
Clinical significance of serum pancreatic enzymes in the quiescent phase of chronic pancreatitis.
Pancreatitis, Chronic
Comparative study of serum pancreatic isoamylase, lipase, and trypsin-like immunoreactivity in pancreatic disease.
Pancreatitis, Chronic
Diagnostic utility of a new monoclonal antibody pancreatic isoamylase assay in chronic pancreatic diseases.
Pancreatitis, Chronic
Differential determination of serum isoamylase using an amylase inhibitor and its clinical application.
Pancreatitis, Chronic
Effect of secretin upon the levels of pancreatic enzymes in blood serum.
Pancreatitis, Chronic
Fecal isoamylase activity in patients with pancreatic diseases.
Pancreatitis, Chronic
Isoamylase determination by isoelectric focusing in pancreatic disorders. A potential clinical aid.
Pancreatitis, Chronic
Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease.
Pancreatitis, Chronic
Serum amylase isozymes in patients with chronic pancreatitis with hyperamylasemia.
Pancreatitis, Chronic
Serum cathodic trypsin-like immunoreactivity, pancreatic lipase, and pancreatic isoamylase as diagnostic tests of chronic pancreatitis or pancreatic steatorrhea.
Pancreatitis, Chronic
Serum immunoreactive trypsin, pancreatic polypeptide, and pancreatic isoamylase as diagnostic tests for chronic pancreatitis.
Pancreatitis, Chronic
Serum pancreatic isoamylase estimation by the inhibitor method as a diagnostic test for chronic pancreatitis.
Pancreatitis, Chronic
Serum phospholipase A2 activity in chronic pancreatic diseases.
Pancreatitis, Chronic
Urinary phospholipase A2 excretion in chronic pancreatic diseases.
Pancreatitis, Chronic
Value of pancreatic-type isoamylase assay as an index of pancreatic insufficiency.
Pancreatitis, Chronic
[Occurrence and nature of hyperamylasemia in chronic alcoholics]
Pancreatitis, Chronic
[Serum pancreatic enzymes in the diagnosis of carcinoma of the pancreas]
Parotid Diseases
[Clinical aspects and therapy of parotid tumors]
Peptic Ulcer
Differential determination of serum isoamylase using an amylase inhibitor and its clinical application.
Peptic Ulcer
The clinical significance of salivary amylase in duodenal aspirates in evaluation of exocrine pancreas function.
Pleural Effusion
A prospective study of amylase-rich pleural effusions with special reference to amylase isoenzyme analysis.
Pneumonia
Amylase in the lung.
Pregnancy, High-Risk
High-risk pregnancies and amniotic fluid isoamylase activity.
Proteinuria
Assessment of glomerular charge selectivity in man by differential clearance of isoamylases.
Renal Insufficiency
Amylase and isoamylase activities in renal insufficiency.
Renal Insufficiency
Immunoreactive trypsin and pancreatic isoamylase activity in serum of patients with chronic renal failure or hepatic cirrhosis.
Renal Insufficiency
P3 isoamylase accompanying renal insufficiency.
Renal Insufficiency
Serum isoamylase measurements in pancreatitis complicating chronic renal failure.
Sialadenitis
Correlation between postsialographical changes of salivary isoamylase levels in serum and histopathological findings in sublingual glands in patients with Sjögren's syndrome.
Steatorrhea
Comparative diagnostic accuracy of four tubeless pancreatic function tests in chronic pancreatitis.
Steatorrhea
Estimation of serum pancreatic isoamylase: its role in the diagnosis of exocrine pancreatic insufficiency.
Steatorrhea
Isoamylase determination by isoelectric focusing in pancreatic disorders. A potential clinical aid.
Steatorrhea
Serum cathodic trypsin-like immunoreactivity, pancreatic lipase, and pancreatic isoamylase as diagnostic tests of chronic pancreatitis or pancreatic steatorrhea.
Urinary Bladder Neoplasms
CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL).
Urinary Bladder Neoplasms
Involvement of glycogen debranching enzyme in bladder cancer.
Urinary Bladder Neoplasms
Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis.
Urinary Bladder Neoplasms
Targeting glycogen metabolism in bladder cancer.
Ventricular Dysfunction, Left
N-methyl-1-deoxynojirimycin (MOR-14), an alpha-glucosidase inhibitor, markedly improves postischemic left ventricular dysfunction.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
3.2.1.68 isoamylase
more
top
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). 
